Atara Biotherapeutics - 53 Year Dividend History | ATRA

Historical dividend payout and yield for Atara Biotherapeutics (ATRA) since 1971. The current TTM dividend payout for Atara Biotherapeutics (ATRA) as of May 24, 2024 is $0.00. The current dividend yield for Atara Biotherapeutics as of May 24, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.078B $0.009B
Atara Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology. The company's lead programs are focused on myostatin and activin, members of the TGF-beta family of proteins that have demonstrated the potential to have therapeutic benefit in a number of clinical indications. Its lead product candidate is PINTA 745, which is in a Phase II clinical trial for the treatment of protein-energy wasting in end-stage renal disease patients. Atara Biotherapeutics, Inc. is headquartered in Brisbane, California.
Stock Name Country Market Cap PE Ratio